|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,934.55 INR | -1.09% |
|
-1.01% | +21.52% |
| 05-15 | Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026 | |
| 05-15 | Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10% | MT |
Business description: Hester Biosciences Limited

Number of employees: 562
Sales by Activity: Hester Biosciences Limited
| Fiscal Period: March | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) |
|---|---|---|---|---|---|
Poultry Healthcare | 1.56B | 1.72B | 1.41B | 1.45B | 1.67B |
Animal Healthcare | 579M | 632M | 1.14B | 1.3B | 1.44B |
Petcare | - | - | 17.67M | 26.41M | - |
Others | - | - | 88.69M | 268M | - |
Geographical breakdown of sales: Hester Biosciences Limited
| Fiscal Period: March | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) |
|---|---|---|---|---|---|
India | 1.71B | 1.9B | 2.17B | 2.39B | 2.61B |
outside India | 432M | 448M | 492M | 654M | 502M |
Executive Committee: Hester Biosciences Limited
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 28/04/1987 | |
Ashish Desai
DFI | Director of Finance/CFO | - | 19/11/2025 |
Vinod Mali
CMP | Compliance Officer | - | 13/05/2018 |
Sumit Gupta
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2007 |
Priya Gandhi
COO | Chief Operating Officer | - | - |
Composition of the Board of Directors: Hester Biosciences Limited
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 27/10/2021 | |
| Chairman | 83 | 20/04/2005 | |
| Director/Board Member | 63 | 28/04/1987 | |
| Director/Board Member | 61 | 28/04/1987 | |
Priya Gandhi
BRD | Director/Board Member | - | 28/10/2021 |
| Director/Board Member | - | 25/06/2023 | |
| Director/Board Member | 44 | 31/03/2020 | |
| Director/Board Member | 74 | 31/03/2020 | |
Anil Jain
BRD | Director/Board Member | - | 25/06/2023 |
Company details: Hester Biosciences Limited

Veterinary Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.09% | -1.01% | +4.44% | +17.65% | 174M | ||
| +4.29% | +7.61% | -50.06% | -49.60% | 34.46B | ||
| +3.46% | +3.68% | +76.01% | +170.42% | 12.24B | ||
| +0.29% | -5.90% | +5.91% | +31.07% | 4.64B | ||
| -0.29% | +0.73% | +6.02% | +17.84% | 3.34B | ||
| +1.01% | +4.27% | +61.32% | +19.70% | 1.93B | ||
| +2.69% | +1.25% | -35.45% | -6.35% | 1.56B | ||
| +2.80% | +14.48% | +34.75% | +141.85% | 1.32B | ||
| -1.22% | -5.71% | -26.63% | -11.27% | 1.03B | ||
| +1.08% | -3.95% | -6.54% | -44.97% | 990M | ||
| Average | +0.69% | +1.41% | +6.98% | +28.63% | 6.17B | |
| Weighted average by Cap. | -0.19% | +4.85% | -10.89% | +12.04% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 524669 Stock
- Company Hester Biosciences Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















